NRC Health is a healthcare consulting and market research firm that helps healthcare systems, providers, and organizations understand and improve the experience of patients, families, consumers, employees, and communities. The company provides human-centered insights and strategic advisory services to transform the healthcare journey and create stronger outcomes. Its business relies on national market research, consumer preference analysis, and empathic heritage to guide decision-making for leading healthcare systems. NRC Health serves the healthcare industry by offering data-driven solutions that support organizational understanding of unique individuals within the healthcare ecosystem.

Summarised from a press release, filed Oct 2026

Industry Healthcare Plans Homepage nrchealth.com
Sector Healthcare IR page nrchealth.com/investor-relations
Tags
healthcare consulting, market research, patient experience, healthcare analytics, strategic advisory, consumer insights, NRC Health, Human Understanding
Press page —

Metrics

Valuation  
Market cap $ 449.684M
Market cap (USD) $ 449.684M
P/E —
PEG —
P/BV -49.30
P/S 3.13
P/OCF 18.92
P/FCF 24.38
Dividend yield 3.0%
Turnover / mcap —
Returns  
ROE 51.2%
ROI 12.5%
ROIC 15.8%
Profit margin 8.4%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -29.2%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 2
Quality score -5.9%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 137.39M 143.06M 148.58M 151.568M 147.954M 133.277M 127.982M 119.686M 117.559M 109.384M 102.343M 98.837M 92.59M 86.421M 75.767M 63.398M 57.692M 51.013M 48.923M 43.771M 32.437M 29.683M 26.922M 22.387M 17.674M 18.316M
Net profit 11.6M 24.783M 30.971M 31.8M 37.466M 37.26M 32.406M 30.047M 22.943M 20.518M 17.61M 18.156M 15.484M 15.068M 11.564M 8.499M 8.491M 7.445M 6.839M 5.884M 5.236M 4.551M 4.384M 3.85M 1.67M 2.717M
Free cash flow 15.744M 19.177M 22.334M 26.43M 40.83M 36.652M 36.261M 33.877M 23.523M 22.87M 18.947M 23.705M 17.127M 16.784M 15.669M 13.064M 10.757M 12.363M 12.61M 5.359M 7.1M 5.75M 6.582M 2.75M 1.536M -4.171M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 18.77 17.64 39.56 37.3 41.52 42.75 65.94 38.14 37.3 19 16.04 13.99 18.82 — — — — — — — — — — — — —
Price performance 12m 0.06 -0.55 0.06 -0.1 -0.03 -0.35 0.73 0.02 0.96 0.18 0.15 -0.26 — — — — — — — — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 10.9M 13.3M 11.9M 11.6M 13.9M 13.7M 14.5M 12.4M 11.1M 11.1M
↳ YoY growth +10.8% +22.8% -10.6% -2.4% +19.6% -1.4% +5.3% -14.4% -10.7% +0.5%
↳ 5y CAGR -0.6% +1.9% +1.5% +7.5% +7.3% +4.8% +1.6% +0.8% -1.0% -4.4%
Borrowings, current (USD) 2.68M 1.07M — — — — — — — 4.01M
Borrowings, non-current (USD) 857,000 — 34.2M 29.8M 26.5M — — 29.5M 57.9M 75M
Lease liabilities (USD) — — 3.23M 786,000 1.27M 818,000 — 2.27M 1.73M 1.21M
Cash and deposits (USD) 33M 34.7M 13M 13.5M 34.7M 54.4M 25M 6.65M 4.23M 4.14M
Intangible assets (USD) 3.12M 2.76M 2.1M 1.73M 1.41M 1.79M 1.61M 1.47M 2.62M 2.23M
Right-of-use assets (USD) — — 2.31M 1.63M 1.31M 975,000 556,000 2.06M 1.63M 1.16M
Net debt (borrowings + leases - cash) (USD) -29.5M -33.7M 21.2M 17.1M -6.87M — — 22.8M 55.4M 72.1M
Cash flow detail
Operating cash flow (USD) 26.8M 28.1M 39.8M 40.9M 40.6M 46.3M 36.3M 38.1M 34.6M 26.5M
Purchases of property, plant and equipment (USD) -3.97M -4.57M -5.97M -4.66M -3.98M -5.51M -9.84M -15.8M -15.4M -10.7M
Purchases of intangible assets (USD) — -250,000 — — — — — — — —
Change in receivables (cash effect) (USD) -1.04M -2.46M 2.77M 311,000 -2.27M 343,000 -733,000 2.08M 1.76M -53,000
Change in payables (cash effect) (USD) -15,000 12,000 -39,000 647,000 -247,000 4,000 -589,000 184,000 -108,000 170,000
Dividends paid (cash effect) (USD) -28.6M -16.9M -16.9M -31.3M -10.5M -9.16M -21M -36.4M -11.5M -11M
Share buybacks (cash effect) (USD) — — — — — -4.14M -27.6M -19.1M -30.9M -20.2M
Interest paid (cash effect) (USD) -192,000 -76,000 -1.28M -2.01M -1.74M -1.55M -1.34M -803,000 -2.44M -4.49M
Income taxes paid (cash effect) (USD) -9.96M -12.8M -2.64M -6.95M -5.22M -10.6M -12.2M -8.93M -8.23M —
Share-based compensation (USD) 1.93M 1.85M 1.51M 1.22M 680,000 623,000 1.2M 935,000 284,000 3.31M
Operating cash flow before change in receivables (USD) 27.9M 30.6M 37.1M 40.6M 42.9M 46M 37M 36M 32.9M 26.5M
Free cash flow (OCF - PPE - intangibles) (USD) 22.9M 23.3M 33.9M 36.3M 36.7M 40.8M 26.4M 22.3M 19.2M 15.7M
Income detail
Total comprehensive income (USD) 20.9M 23.9M 28.8M 33.1M 37.1M 37.5M 34.2M 31M 24.8M —
Comprehensive income to owners (USD) 20.9M 23.9M 28.8M 33.1M 37.1M 37.5M 34.2M 31M 24.8M —
Provision for credit losses (USD) 218,000 249,000 80,000 75,000 46,000 38,000 19,000 99,000 -76,000 216,000
Credit cost ratio (credit losses / average receivables) (%) 2.1% 2.1% 0.6% 0.6% 0.4% 0.3% 0.1% 0.7% 0.6% 1.9%
Reported Mar 14, 2018 Mar 14, 2018 May 8, 2019 Mar 6, 2020 Mar 5, 2021 Mar 4, 2022 Mar 3, 2023 Mar 17, 2025 Mar 17, 2025 Aug 4, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

1245 Q Street, Lincoln, NE 68508 Bull 3 Bear 0 Results

P: 1 800 388 4264 | F: 402 475 9061

nrchealth.com

NRC HEALTH ANNOUNCES THIRD QUARTER 2026 RESULTS

Third quarter revenue increased 11% year-over-year to $38.4 million

Third quarter TRCV* increased 9% year-over-year to $154.1 million

LINCOLN, Nebraska, October 27, 2026 — NRC Health (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced results for the third quarter 2026.

“We delivered a strong third quarter, with revenue up 11% year-over-year and sequential margin expansion,” said Trent Green, CEO of NRC Health. “Our large customer went live on schedule, and several long-standing customers renewed under multi-year agreements, reinforcing the durability of our recurring-revenue base.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 14, 2026, the board of directors of NRC Health, a Delaware corporation (the "Company"), designated Trent Green, the Company’s Chief Executive Officer, to serve as the Company’s interim principal financial officer. There were no compensation changes in connection with the appointment of Mr. Green. There are no arrangements or understandings between Mr. Green and any other person pursuant to which Mr. Green was appointed to serve as interim principal financial officer. Mr. Green does not have a direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

The following is biographical information for Mr. Green:

Trent Green, 54, has served as our Chief Executive Officer since June 2025. Prior to joining the Company, Mr. Green served as Chief Executive Officer of Amazon One Medical, a hybrid primary care provider owned by Amazon, from September 2023 to February 2025 and as Chief Operating Officer of Amazon One Medical from July 2022 through August 2023.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 7, 2026, Shane Harrison, Chief Financial Officer and principal financial officer of NRC Health, a Delaware corporation (the "Company"), tendered his resignation from the Company in order to pursue an outside professional opportunity. Mr. Harrison’s resignation is effective August 28, 2026. The Company has initiated a search process for a new Chief Financial Officer.

Prompts

NRC Health (ticker NRC), listed in United States.

Company History

Date Change Detail
Apr 20, 2026 Renamed NATIONAL RESEARCH CORP → NRC HEALTH

ETFs Holding NRC Health

ETF Weight in ETF Shares Market value As of
RFDA 1.10% 43,229 $ 905.215K Aug 31, 2026
AVSC 0.03% 33,096 $ 871.418K Nov 16, 2026
SFGV 0.03% 12,544 $ 320K Nov 18, 2026
DFAS 0.01% 158,240 $ 4.216M Nov 12, 2026
DXUV 0.01% 15,436 $ 411.215K Nov 12, 2026
EBI 0.00% 987 $ 20.668K Aug 31, 2026
DFSU 0.00% 2,149 $ 57.249K Nov 12, 2026
DFAC 0.00% 56,655 $ 1.509M Nov 12, 2026
MSSM 0.00% 438 $ 9,171.72 Aug 31, 2026
DCOR 0.00% 18,913 $ 503.842K Nov 12, 2026
DFAU 0.00% 4,118 $ 109.704K Nov 12, 2026
DFUS 0.00% 2,478 $ 66.014K Nov 12, 2026
AVUS 0.00% 4,055 $ 106.768K Nov 16, 2026
AVSU 0.00% 476 $ 12.533K Nov 16, 2026